Study Information
| Title: | A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)  |
| Status: | Recruiting participants |
| Conditions: | Non Small Cell Lung Cancer |
| Interventions: | Drug: STA 9090 |
| Institutions: | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital |
| Health Topics: | Adenocarcinoma of the Lung, Lung Cancer Overview, Squamous cell carcinoma of the lung |
Contact Information
Beth Israel Deaconess Medical Center
Boston, MA 02215
Kelly Masone
617-667-1925
Dana Farber Cancer Institute
Boston, MA 02115
Joan Lucca, RN, NP-C
617-632-5403
jlucca@partners.org
Massachusetts General Hospital
Boston, MA 02114
Patricia Ostler, RN
617-724-7829
postler@partners.org